Over 18 Years OldNCT07155720
Effects of Kinesio Taping on Premenstrual Syndrome
A study testing Intervention (Kinesio Taping) group in people with Over 18 Years Old, run by Yağmur SÜRMELİ AKBAL at 1 site in Turkey (Türkiye).
Trial summary
This randomized, single-blind study aimed to evaluate the effects of kinesio taping on PMS symptoms, happiness, and quality of life. The primary question(s) it aimed to answer were: Is there a significant difference in premenstrual symptoms, happiness, and quality of life between the kinesio taping intervention group… Read more about this study
- Who is it for?
- Ages 18 to 45 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Over 18 Years Old
- What is being tested?
- Intervention (Kinesio Taping) group
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 72 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Oct 2025to 1 Mar 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Being 18 years of age or older
- Scoring at least 110 on the Premenstrual Syndrome Scale
- Having regular menstrual cycles between 28 and 35 days
- Not having any psychiatric diagnoses and not using psychiatric medications
- Not having any serious chronic diseases (e.g., diabetes, thyroid disease, cardiovascular disease)
- Being willing to participate in the study and open to communication
- Not using oral contraceptives
Who cannot join
- Having been diagnosed with an allergic skin disease
- Being pregnant
- Having a history of allergy to kinesio tape
- Having a diagnosed psychiatric disorder
- Regularly using kinesio tape
- Having serious chronic illnesses
- Student groups taught by the practitioner and the researcher
- Voluntarily withdrawing from the study
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Kinesio Taping on Premenstrual Syndrome, Happiness, and Quality of Life
This randomized, single-blind study aimed to evaluate the effects of kinesio taping on PMS symptoms, happiness, and quality of life.
The primary question(s) it aimed to answer were:
Is there a significant difference in premenstrual symptoms, happiness, and quality of life between the kinesio taping intervention group and the sham taping placebo group?
Read the detailed description
The population of this study will consist of first-year female students studying in the health department at a university in the Mediterranean region between October 2025 and January 2026. The study sample will consist of women who meet the inclusion criteria and volunteer. The sample size was determined by the statistician using power analysis using the G*Power 3.1.9.4 package program. Since no studies in the literature have been found evaluating kinesio taping applied to students experiencing PMS together with the Premenstrual Syndrome Scale, the Oxford Happiness Scale, or the Premenstrual Syndrome-Specific Quality of Life Scale, Cohen's effect size values were used in the calculations. Accordingly, if an effect size was taken as 0.25, a type I error level of 0.05, a statistical power of 0.80, and a correlation coefficient between repeated measurements of 0.5, a total of 28 participants was deemed sufficient, with a minimum of 14 participants for each group. However, to prevent potential sample losses from impacting statistical power, a 25% attrition margin was anticipated, and the study was planned to include a minimum of 42 students (21 intervention, 21 placebo). Participants will be randomly selected from individuals diagnosed with PMS who meet the study criteria and divided into two groups: the intervention group (n=21) and the placebo group (n=21). Therefore, the study is planned to include a total of 42 participants.
Study participants will be assigned to intervention and placebo groups using the randomization method (https://www.randomizer.org). Data will be uploaded to the program by assigning codes to the intervention and placebo groups. Therefore, the study will also be blinded for statistical analysis and reporting. Data will be collected using the Premenstrual Syndrome Scale, the Oxford Happiness Scale, or the Premenstrual Syndrome-Specific Quality of Life Scale.
Implementation Procedure: Researcher Lecturer Yağmur Sürmeli (Y.S.) has received the internationally recognized "Kinesiology Taping Practitioner Training Certificate," which will ensure the effectiveness and efficiency of the implementation plan. Before starting the interventions, students will be provided with detailed information about the study; the researchers will assess the inclusion and exclusion criteria of students who agree to participate and sign the "Voluntary Consent Form." Before starting the kinesiology taping intervention, participants in both groups will be administered a "Descriptive Characteristics Information Form," the "Premenstrual Syndrome Scale," the Oxford Happiness Scale, and the "Premenstrual Syndrome-Specific Quality of Life Scale." Student privacy will be protected throughout the intervention, and they will be asked not to remove the tapes. Students will be instructed on how to remove the tapes and whether they should be removed before the next intervention.
Intervention Group: Students in this group will receive 100% cotton, latex-free, 5 cm x 0.5 cm original brand Kinesio Tex Gold™® kinesio tape. Application will begin one week before the estimated date of menstruation, which is when PMS symptoms are most likely to be intense. The tape will be removed on the third day after application, and a one-day break will be taken. Then, taping will be repeated in the same areas with the same tension. The application will end on the fourth day of menstruation. Kinesio taping will begin again one week before the estimated start of the next menstrual period, and the application will be repeated using the same technique as the previous month. Before each application, the skin to which the tapes will be applied will be wiped with a dry napkin. The tapes will be applied in a cross shape with 100% tension over the sacrum and in a star shape with 25-50% tension just below the clavicle. Students will complete the Premenstrual Syndrome Scale, the Oxford Happiness Scale Short Form, and the Premenstrual Syndrome-Specific Quality of Life Scale before taping, on the 4th day of their first and second menstrual periods, and on the 4th day of their third menstrual period (when the procedure is not performed).
Placebo Group: Women in this group will receive sham taping (tension-free kinesio taping). The quality of the kinesio taping will be the same as that used in the intervention group. Students will complete the Premenstrual Syndrome Scale, the Oxford Happiness Scale Short Form, and the Premenstrual Syndrome-Specific Quality of Life Scale before taping, on the 4th day of their first and second menstrual periods, and on the 4th day of their third menstrual period (when the procedure is not performed).
Statistics Statistical analysis of the data will be performed using the IBM SPSS Statistics 24.0 (IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY) program. Percentage, arithmetic mean and standard deviation will be calculated in the analysis of the data. In comparing the data between two groups, Independent Two Samples t-Test (if distribution is normal) or Mann-Whitney U Test (if distribution is not normal) will be performed for continuous variables, Chi-Square Test (if data is large enough) or Fisher's Exact Test (if sample is small) will be performed for categorical variables. Repeated Measures Analysis of Variance (ANOVA), if assumptions cannot be met, non-parametric tests such as Friedman Test will be used. Bonferroni correction will be applied for interactions. In all analyses, p<0.05 will be accepted as the statistical significance level.
Ethical Aspects of the Research Ethics committee and institutional approvals will be obtained for the study. The research will be conducted in accordance with the rules of the Declaration of Helsinki (World Medical Association, 2013). All women participating in the study will be informed and their written and verbal consent will be obtained.
- Conditions
- Over 18 Years Old
- Being tested
- Intervention (Kinesio Taping) group
- Keywords
- kinesio-tape, kinesio-taping, nursing, happiness, quality of life
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Intervention (Kinesio Taping) groupOther
No studies have been found in the literature examining whether kinesio taping increases happiness in women with PMS.
| Study group | Role | What they receive |
|---|---|---|
| Kinesio Taping | Experimental | Kinesio tape will be applied with 100% tension. Receives: Other: Intervention (Kinesio Taping) group |
| Sham Taping | Placebo comparator | Kinesio tape will be applied without tension. Receives: Other: Intervention (Kinesio Taping) group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Premenstrual Syndrome Scale
The Premenstrual Syndrome Scale was developed by Gençdoğan in 2006 to determine premenstrual symptoms. It is a five-point Liker-type scale consisting of 44 items and 9 subscales (pain, bloating, cough, anger, anxiety, depressive affect, depressive thoughts, and sleep). The lowest score on the scale is 44, and the highest is 220. The score characteristics on the scale are the increase in the intensity of PMS indicators. A minimum total score of 110 points on the PMS is classified as PMS positive. The Cronbach's α value of the scale is 0.75.
Measured: 12 weeks
Secondary outcomes (2)
Oxford Happiness Scale Short Form
Developed by Hills and Argyle (2002) and adapted into Turkish by Doğan and Akıncı-Çötok (2011), the scale is a 5-point Likert-type scale with 7 items. As the score obtained from the scale increases, the happiness level of the individual increases. The Cronbach's α value for the scale was found to be 0.74.
Measured: 12 weeks
Premenstrual Syndrome-Specific Quality of Life Scale
The Premenstrual Syndrome-Specific Quality of Life Scale was developed by Hadavi-Bavili and İlçioğlu in 2024. The scale consists of three subscales: physical (first 11 items), emotional (items 12-18), and social (items 19-22). All items on the scale are reverse-coded. The minimum score is 22, and the maximum score is 110. Cronbach's α for the physical subscale of the scale was 0.868, for the emotional subscale was 0.846, and for the social subscale was 0.676. The scale's Cronbach's α was found to be 0.90. As the score on the scale increases, so does the quality of life.
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Sep 2025
- Study start1 Oct 2025
- Primary completion31 Jan 2026
- Study completion1 Mar 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Over 18 Years OldStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 72 participants (actual)
Sponsor and investigators
- Lead sponsor
- Yağmur SÜRMELİ AKBAL
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Yağmur SÜRMELİ AKBAL, Mersin University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07155720
- Sponsor's protocol ID
- 2024/009
- Status last verified
- Oct 2026
- First submitted
- 20 Aug 2025
- Last updated
- 22 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Kinesio Taping on Premenstrual Syndrome, Happiness, and Quality of Life
- ClinicalTrials.gov ID
- NCT07155720
- Acronym / sponsor ID
- 2024/009
- Conditions
- Over 18 Years Old
- Keywords
- kinesio-tape, kinesio-taping, nursing, happiness, quality of life
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 72 participants (actual)
- Lead sponsor
- Yağmur SÜRMELİ AKBALUniversity, hospital or other
- Study start
- 1 Oct 2025 (actual)
- Primary completion
- 31 Jan 2026 (actual)
- Study completion
- 1 Mar 2026 (actual)
- First posted
- 4 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized, single-blind study aimed to evaluate the effects of kinesio taping on PMS symptoms, happiness, and quality of life.
The primary question(s) it aimed to answer were:
Is there a significant difference in premenstrual symptoms, happiness, and quality of life between the kinesio taping intervention group and the sham taping placebo group?
Detailed description
The population of this study will consist of first-year female students studying in the health department at a university in the Mediterranean region between October 2025 and January 2026. The study sample will consist of women who meet the inclusion criteria and volunteer. The sample size was determined by the statistician using power analysis using the G*Power 3.1.9.4 package program. Since no studies in the literature have been found evaluating kinesio taping applied to students experiencing PMS together with the Premenstrual Syndrome Scale, the Oxford Happiness Scale, or the Premenstrual Syndrome-Specific Quality of Life Scale, Cohen's effect size values were used in the calculations. Accordingly, if an effect size was taken as 0.25, a type I error level of 0.05, a statistical power of 0.80, and a correlation coefficient between repeated measurements of 0.5, a total of 28 participants was deemed sufficient, with a minimum of 14 participants for each group. However, to prevent potential sample losses from impacting statistical power, a 25% attrition margin was anticipated, and the study was planned to include a minimum of 42 students (21 intervention, 21 placebo). Participants will be randomly selected from individuals diagnosed with PMS who meet the study criteria and divided into two groups: the intervention group (n=21) and the placebo group (n=21). Therefore, the study is planned to include a total of 42 participants.
Study participants will be assigned to intervention and placebo groups using the randomization method (https://www.randomizer.org). Data will be uploaded to the program by assigning codes to the intervention and placebo groups. Therefore, the study will also be blinded for statistical analysis and reporting. Data will be collected using the Premenstrual Syndrome Scale, the Oxford Happiness Scale, or the Premenstrual Syndrome-Specific Quality of Life Scale.
Implementation Procedure: Researcher Lecturer Yağmur Sürmeli (Y.S.) has received the internationally recognized "Kinesiology Taping Practitioner Training Certificate," which will ensure the effectiveness and efficiency of the implementation plan. Before starting the interventions, students will be provided with detailed information about the study; the researchers will assess the inclusion and exclusion criteria of students who agree to participate and sign the "Voluntary Consent Form." Before starting the kinesiology taping intervention, participants in both groups will be administered a "Descriptive Characteristics Information Form," the "Premenstrual Syndrome Scale," the Oxford Happiness Scale, and the "Premenstrual Syndrome-Specific Quality of Life Scale." Student privacy will be protected throughout the intervention, and they will be asked not to remove the tapes. Students will be instructed on how to remove the tapes and whether they should be removed before the next intervention.
Intervention Group: Students in this group will receive 100% cotton, latex-free, 5 cm x 0.5 cm original brand Kinesio Tex Gold™® kinesio tape. Application will begin one week before the estimated date of menstruation, which is when PMS symptoms are most likely to be intense. The tape will be removed on the third day after application, and a one-day break will be taken. Then, taping will be repeated in the same areas with the same tension. The application will end on the fourth day of menstruation. Kinesio taping will begin again one week before the estimated start of the next menstrual period, and the application will be repeated using the same technique as the previous month. Before each application, the skin to which the tapes will be applied will be wiped with a dry napkin. The tapes will be applied in a cross shape with 100% tension over the sacrum and in a star shape with 25-50% tension just below the clavicle. Students will complete the Premenstrual Syndrome Scale, the Oxford Happiness Scale Short Form, and the Premenstrual Syndrome-Specific Quality of Life Scale before taping, on the 4th day of their first and second menstrual periods, and on the 4th day of their third menstrual period (when the procedure is not performed).
Placebo Group: Women in this group will receive sham taping (tension-free kinesio taping). The quality of the kinesio taping will be the same as that used in the intervention group. Students will complete the Premenstrual Syndrome Scale, the Oxford Happiness Scale Short Form, and the Premenstrual Syndrome-Specific Quality of Life Scale before taping, on the 4th day of their first and second menstrual periods, and on the 4th day of their third menstrual period (when the procedure is not performed).
Statistics Statistical analysis of the data will be performed using the IBM SPSS Statistics 24.0 (IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY) program. Percentage, arithmetic mean and standard deviation will be calculated in the analysis of the data. In comparing the data between two groups, Independent Two Samples t-Test (if distribution is normal) or Mann-Whitney U Test (if distribution is not normal) will be performed for continuous variables, Chi-Square Test (if data is large enough) or Fisher's Exact Test (if sample is small) will be performed for categorical variables. Repeated Measures Analysis of Variance (ANOVA), if assumptions cannot be met, non-parametric tests such as Friedman Test will be used. Bonferroni correction will be applied for interactions. In all analyses, p<0.05 will be accepted as the statistical significance level.
Ethical Aspects of the Research Ethics committee and institutional approvals will be obtained for the study. The research will be conducted in accordance with the rules of the Declaration of Helsinki (World Medical Association, 2013). All women participating in the study will be informed and their written and verbal consent will be obtained.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Kinesio Taping | Experimental | Other: Intervention (Kinesio Taping) groupKinesio tape will be applied with 100% tension. |
| Sham Taping | Placebo comparator | Other: Intervention (Kinesio Taping) groupKinesio tape will be applied without tension. |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Being 18 years of age or older
- Scoring at least 110 on the Premenstrual Syndrome Scale
- Having regular menstrual cycles between 28 and 35 days
- Not having any psychiatric diagnoses and not using psychiatric medications
- Not having any serious chronic diseases (e.g., diabetes, thyroid disease, cardiovascular disease)
Key exclusion criteria (8 listed)
- Having been diagnosed with an allergic skin disease
- Being pregnant
- Having a history of allergy to kinesio tape
- Having a diagnosed psychiatric disorder
- Regularly using kinesio tape
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Intervention (Kinesio Taping) groupNo studies have been found in the literature examining whether kinesio taping increases happiness in women with PMS. | Other | Kinesio Taping, Sham Taping |
Primary outcome
Premenstrual Syndrome Scale
Time frame: 12 weeks
The Premenstrual Syndrome Scale was developed by Gençdoğan in 2006 to determine premenstrual symptoms. It is a five-point Liker-type scale consisting of 44 items and 9 subscales (pain, bloating, cough, anger, anxiety, depressive affect, depressive thoughts, and sleep). The lowest score on the scale is 44, and the highest is 220. The score characteristics on the scale are the increase in the intensity of PMS indicators. A minimum total score of 110 points on the PMS is classified as PMS positive. The Cronbach's α value of the scale is 0.75.
2 secondary outcomes
Oxford Happiness Scale Short Form
Time frame: 12 weeks
Premenstrual Syndrome-Specific Quality of Life Scale
Time frame: 12 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Over 18 Years Old
Not yet recruitingPhase 3
The Effects of Bromelain Supplement in Patients with Diabetic Foot Ulcers
Diabetic Foot Ulcer (DFU)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Intervention (Kinesio Taping) group in people with Over 18 Years Old, run by Yağmur SÜRMELİ AKBAL at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Premenstrual Syndrome Scale (time frame: 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2026.